Efficacy and safety of roflumilast cream for chronic plaque psoriasis with facial/neck and intertriginous area involvement: a post hoc analysis from a randomized controlled trial

Author:

Draelos Zoe D1,Adam David N2,Hong H Chih-ho3,Lebwohl Mark G4,Lynde Charles W5,Nahm Walter K6,Papp Kim A7ORCID,Pariser David M8,Stein Gold Linda9,Stewart Daniel10,Higham Robert C11,Berk David R11,Krupa David11,Burnett Patrick11

Affiliation:

1. Dermatology Consulting Services , High Point, NC , USA

2. CCA Medical Research, Probity Medical Research and Temerty Faculty of Medicine, University of Toronto , Toronto, ON , Canada

3. Department of Dermatology and Skin Science, University of British Columbia and Probity Medical Research , Surrey, BC , Canada

4. Icahn School of Medicine at Mount Sinai , New York, NY , USA

5. University of Toronto, Toronto, Lynde Centre for Dermatology, Markham, and Probity Medical Research , Markham, ON , Canada

6. University of California, San Diego, School of Medicine , San Diego, CA , USA

7. Probity Medical Research and K Papp Clinical Research , Waterloo, ON , Canada

8. Eastern Virginia Medical School and Virginia Clinical Research , Inc., Norfolk, VA , USA

9. Henry Ford Medical Center , Detroit, MI , USA

10. Michigan Center for Skin Care Research , Clinton Township, MI , USA

11. Arcutis, Inc. , Westlake Village, CA , USA

Abstract

This post hoc analysis evaluated efficacy and safety of roflumilast cream in patients with psoriasis involving the face/neck or intertriginous areas from a phase IIb trial. Of 331 patients enrolled in the phase IIb trial, 160 had psoriasis involving the face/neck and/or intertriginous areas. Once-daily roflumilast cream was well tolerated with efficacy across multiple endpoints in these patients.

Funder

Arcutis Biotherapeutics, Inc

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Reference8 articles.

1. Psoriasis in special localizations;Dopytalska;Reumatologia,2018

2. Joint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures;Elmets;J Am Acad Dermatol,2021

3. Treatment of inverse/intertriginous psoriasis: updated guidelines from the Medical Board of the National Psoriasis Foundation;Khosravi;J Drugs Dermatol,2017

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Quoi de neuf en thérapeutique dermatologique ?;Annales de Dermatologie et de Vénéréologie - FMC;2023-12

2. Roflumilast 0.3% Cream: a Phosphodiesterase 4 Inhibitor for the Treatment of Chronic Plaque Psoriasis;American Journal of Therapeutics;2023-11

3. Topical roflumilast for the treatment of psoriasis;Expert Review of Clinical Immunology;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3